[ORGANIZATION]
AeroVironment, Inc.
Featured in 2 tracked stories · first seen
Situations
Oruka Therapeutics drug development expansion
2 clusters · 5 sources · last updated
Latest: Oracle and Sumitomo Mitsui see notable stock transactions
Oruka Therapeutics has expanded the development rights for its lead IL-23 program, ORKA-001, to include inflammatory bowel disease (IBD) following an amended license agreement with Paragon Therapeutics. The company is cu
Institutional investment shifts and corporate earnings
2 clusters · 6 sources · last updated
Latest: Corporate financial reports show mixed results for Broadcom, York Space Systems, and AVAX One
Recent SEC filings and financial reports indicate significant adjustments to holdings by institutional investors and mixed performance across various sectors, including mining, biotechnology, semiconductors, and pharmace